ARM Reprices to 100x Forward P/E on Vera Royalties Analysts Cap at $400M-$1B

ARM Holdings soared 15% to $256.59 this week following Nvidia's blockbuster $91B Q2 guidanceCompany-issued forecasts of future financial performance., riding market enthusiasm over the company's disclosed Vera CPU initiative. Market participants extrapolated potential royalty revenues for ARM on the assumption that Vera could generate $20B in standalone CPU revenue, implying ARM royalties of $400M to $1B annually. This repricing lifted ARM's forward P/E to approximately 100x, an extreme valuation that contrasts sharply with Nvidia's 33x forward multiple.

However, detailed analysis from market observers suggests the market may be pricing Vera royalties at an inflated rate. ARM's licensing model typically captures 2-5% of a chip's revenue stream via royalties and design fees. If Vera achieves $20B in revenue, ARM's upside would be capped at roughly $400M to $1B annually, not the $1B-plus pricing the stock currently appears to embed. This implies a meaningful gap between current ARM valuation and realistic earnings power from the Vera relationship.

The repricing dynamic reflects a broader market theme: Nvidia's success has become so dominant that any hint of shared upside gets rapidly capitalised into supplier and competitor valuations. ARM is benefiting from the coattails of Nvidia's AI momentumThe empirical fact that winners keep winning over the medium term. even as the actual financial benefit to ARM remains capped by its licensing economics. Nvidia itself closed relatively flat despite record guidanceCompany-issued forecasts of future financial performance., suggesting the market had already priced in strong AI capex demand and that the bar for positive surprise is extremely high.

Investors debate whether ARM's rally is sustainable or represents a temporary rerating that will compress once the Vera royalty reality becomes clearer. The valuation disconnect between ARM at 100x forward P/E and Nvidia at 33x suggests either ARM is significantly undervalued on a longer-term view or the market is temporarily mispricing the magnitude of royalty upside. Earnings revisions and detailed Vera roadmap disclosures will be critical to clarifying this dynamic.